The Comparison About the Response of Ursodeoxycholic Acid in Primary Biliary Cholangitis Only and Primary Biliary Cholangitis With High Immune Globulin G or Aminotransferase at West China Hospital
Completed
- Conditions
- Primary Biliary Cholangitis
- Registration Number
- NCT03322943
- Lead Sponsor
- West China Hospital
- Brief Summary
This study evaluates the different response of Ursodeoxycholic Acid in primary biliary cholangitis only and primary biliary cholangitis with high immune globulin G or aminotransferase at West China Hospital from 2008-2017.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Patients diagnosed with primary biliary cholangitis Treated with Ursodeoxycholic Acid in West China Hospital for at least 1 year
Exclusion Criteria
Autoimmune hepatitis Primary sclerosing cholangitis
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Description of demographics, clinical index after treatment up to 1 year age，sex，ALT（IU/L），AST（IU/L），ALP（IU/L），GGT（IU/L）,IgG（g/L）
- Secondary Outcome Measures
Name Time Method Evaluation whether the PBC patients have response after treatment within 1 year Use Paris II criterion to estimate
Trial Locations
- Locations (1)
West China Hospital
🇨🇳Chengdu, Sichuan, China